➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Boehringer Ingelheim
Medtronic
Merck
AstraZeneca
McKesson

Last Updated: July 29, 2021

DrugPatentWatch Database Preview

Us Antibiotics Company Profile


Email this page to a colleague

« Back to Dashboard

What is the competitive landscape for US ANTIBIOTICS, and what generic and branded alternatives to US ANTIBIOTICS drugs are available?

US ANTIBIOTICS has twenty approved drugs.



Summary for Us Antibiotics
US Patents:0
Tradenames:16
Ingredients:8
NDAs:20

Drugs and US Patents for Us Antibiotics

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Us Antibiotics AMOXIL amoxicillin FOR SUSPENSION;ORAL 050760-001 Apr 15, 1999 DISCN Yes No ⤷  Try it Free ⤷  Try it Free
Us Antibiotics AMOXIL amoxicillin FOR SUSPENSION;ORAL 050760-002 Apr 15, 1999 DISCN Yes No ⤷  Try it Free ⤷  Try it Free
Us Antibiotics AMOXIL amoxicillin CAPSULE;ORAL 062216-004 Approved Prior to Jan 1, 1982 AB RX No No ⤷  Try it Free ⤷  Try it Free
Us Antibiotics ALENDRONATE SODIUM alendronate sodium TABLET;ORAL 079049-002 Aug 4, 2008 DISCN No No ⤷  Try it Free ⤷  Try it Free
Us Antibiotics AUGMENTIN '875' amoxicillin; clavulanate potassium TABLET;ORAL 050720-001 Feb 13, 1996 AB RX Yes No ⤷  Try it Free ⤷  Try it Free
Us Antibiotics LAROTID amoxicillin FOR SUSPENSION;ORAL 062226-004 Approved Prior to Jan 1, 1982 AB RX No No ⤷  Try it Free ⤷  Try it Free
Us Antibiotics IRBESARTAN irbesartan TABLET;ORAL 203161-003 Sep 27, 2012 DISCN No No ⤷  Try it Free ⤷  Try it Free
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for Us Antibiotics

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Us Antibiotics AUGMENTIN XR amoxicillin; clavulanate potassium TABLET, EXTENDED RELEASE;ORAL 050785-001 Sep 25, 2002 6,746,692 ⤷  Try it Free
Us Antibiotics AUGMENTIN XR amoxicillin; clavulanate potassium TABLET, EXTENDED RELEASE;ORAL 050785-001 Sep 25, 2002 6,878,386 ⤷  Try it Free
Us Antibiotics AUGMENTIN XR amoxicillin; clavulanate potassium TABLET, EXTENDED RELEASE;ORAL 050785-001 Sep 25, 2002 7,250,176 ⤷  Try it Free
Us Antibiotics AUGMENTIN XR amoxicillin; clavulanate potassium TABLET, EXTENDED RELEASE;ORAL 050785-001 Sep 25, 2002 7,217,430 ⤷  Try it Free
Us Antibiotics AUGMENTIN XR amoxicillin; clavulanate potassium TABLET, EXTENDED RELEASE;ORAL 050785-001 Sep 25, 2002 6,783,773 ⤷  Try it Free
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration
Paragraph IV (Patent) Challenges for US ANTIBIOTICS drugs
Drugname Dosage Strength Tradename Submissiondate
➤ Subscribe Extended-release Tablets 1000 mg/62.5 mg ➤ Subscribe 2009-01-21
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Merck
Baxter
Colorcon
AstraZeneca
Express Scripts
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.